CLIAC Reaffirms Quality, Comparability In Waiver Criteria Proposal To HHS
This article was originally published in The Gray Sheet
Executive Summary
Quality control testing requirements should be included in manufacturer instructions for CLIA-waived assays to compensate for the potential inexperience of lab personnel, the Clinical Laboratory Improvement Advisory Committee (CLIAC) is urging HHS